Results 271 to 278 of about 1,994,731 (278)

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Roles of the RANKL–RANK axis in antitumour immunity — implications for therapy

Nature Reviews Clinical Oncology, 2018
Mark J Smyth, William C Dougall, Michele W L Teng   +2 more
exaly  

The role of Fas ligand in immune privilege

Nature Reviews Molecular Cell Biology, 2001
Douglas R Green
exaly  

Combination cancer immunotherapy and new immunomodulatory targets

Nature Reviews Drug Discovery, 2015
Kathleen M Mahoney, Gordon J Freeman
exaly  

PL5.1. RANK ligand signaling system in malignancy

Cancer Treatment Reviews, 2008
openaire   +1 more source

Notch signalling in context

Nature Reviews Molecular Cell Biology, 2016
Sarah Bray
exaly  

Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab

Nature Reviews Drug Discovery, 2012
exaly  

RANK ligand inhibition: Experiences from rodents to primates

Bone, 2009
openaire   +1 more source